Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay Sethi

Showing results (181-190 of 206) with videos related to

Pageof 21
Sort By:
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 31, 2017
Erratum: Erratum: Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension™ Delivery Technology Versus Foradil® Aerolizer® in Moderate-To-Severe COPD: A Randomized, Dose-Ranging StudySanjay Sethi, Charles Fogarty, Nicola A Hanania, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension™ Delivery Technology Versus Foradil® Aerolizer® in Moderate-To-Severe COPD: A Randomized, Dose-Ranging StudySanjay Sethi, Charles Fogarty, Nicola A Hanania, et al.
American Journal of Respiratory and Critical Care Medicine|September 2, 2016
Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical TrialFernando J Martinez, Klaus F Rabe, Sanjay Sethi, et al.
Respiratory Research|August 21, 2019
Compartmentalization of anti-oxidant and anti-inflammatory gene expression in current and former smokers with COPDVenkataramana K Sidhaye, Janet T Holbrook, Alyce Burke, et al.
American Journal of Respiratory and Critical Care Medicine|June 4, 2015
IL-17A and the Promotion of Neutrophilia in Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseAbraham B Roos, Sanjay Sethi, Jake Nikota, et al.
The European Respiratory Journal|April 14, 2017
The microbiome in respiratory medicine: current challenges and future perspectivesRosa Faner, Oriol Sibila, Alvar Agustí, et al.
Respiratory Research|September 3, 2016
Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPDLeonardo M Fabbri, Edward M Kerwin, Selwyn Spangenthal, et al.
Nature Protocols|December 9, 2022
High-quality and robust protein quantification in large clinical/pharmaceutical cohorts with IonStar proteomics investigationShichen Shen, Xue Wang, Xiaoyu Zhu, et al.
BMJ Open|July 24, 2025
Future exacerbations and mortality rates among patients experiencing COPD exacerbations: a meta-analysis of results from the EXACOS/AVOIDEX programmeKirsty Rhodes, Deven Patel, My Linh Duong, et al.
Plos One|March 29, 2017
Correction: Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled TrialRobert A Wise, Janet T Holbrook, Gerard Criner, et al.
Pageof 21

Showing results (181-190 of 206) with videos related to

Sort By:
Pageof 21
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 31, 2017
Erratum: Erratum: Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension™ Delivery Technology Versus Foradil® Aerolizer® in Moderate-To-Severe COPD: A Randomized, Dose-Ranging StudySanjay Sethi, Charles Fogarty, Nicola A Hanania, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension™ Delivery Technology Versus Foradil® Aerolizer® in Moderate-To-Severe COPD: A Randomized, Dose-Ranging StudySanjay Sethi, Charles Fogarty, Nicola A Hanania, et al.
American Journal of Respiratory and Critical Care Medicine|September 2, 2016
Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical TrialFernando J Martinez, Klaus F Rabe, Sanjay Sethi, et al.
Respiratory Research|August 21, 2019
Compartmentalization of anti-oxidant and anti-inflammatory gene expression in current and former smokers with COPDVenkataramana K Sidhaye, Janet T Holbrook, Alyce Burke, et al.
American Journal of Respiratory and Critical Care Medicine|June 4, 2015
IL-17A and the Promotion of Neutrophilia in Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseAbraham B Roos, Sanjay Sethi, Jake Nikota, et al.
The European Respiratory Journal|April 14, 2017
The microbiome in respiratory medicine: current challenges and future perspectivesRosa Faner, Oriol Sibila, Alvar Agustí, et al.
Respiratory Research|September 3, 2016
Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPDLeonardo M Fabbri, Edward M Kerwin, Selwyn Spangenthal, et al.
Nature Protocols|December 9, 2022
High-quality and robust protein quantification in large clinical/pharmaceutical cohorts with IonStar proteomics investigationShichen Shen, Xue Wang, Xiaoyu Zhu, et al.
BMJ Open|July 24, 2025
Future exacerbations and mortality rates among patients experiencing COPD exacerbations: a meta-analysis of results from the EXACOS/AVOIDEX programmeKirsty Rhodes, Deven Patel, My Linh Duong, et al.
Plos One|March 29, 2017
Correction: Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled TrialRobert A Wise, Janet T Holbrook, Gerard Criner, et al.
Pageof 21